The Foundation for Innovative New Diagnostics (FIND) is a global health non-profit that engages in over 150 collaborations to facilitate the development, evaluation, and implementation of diagnostic tests for poverty-related diseases. The organization focuses on improving diagnosis in several disease areas, as well as diagnostic connectivity, outbreak preparedness, development of target product profiles and negotiating preferential product pricing for developing markets.
To support this work, FIND has sought to create two collaborative marketplaces via UHC-DM: the COVID-19 eCatalogue, an information portal for COVD-19 related diagnostics, and the GDA marketplace, a marketplace for diagnostics procurement for diseases including hepatitis C, HIV, malaria, neglected tropical diseases, and tuberculosis.
FIND has launched an information portal or e-catalogue that will provide visibility on COVID-19 diagnostics available on the market as well as their indicative prices. This diagnostics resource centre is designed to support policymakers and healthcare providers with up-to-date information on tests and testing for SARS-CoV-2 (the causative agent of COVID-19), with interested buyers being redirected to other agencies’ procurement portals to place orders.
The COVID-19 eCatalogue is part of FIND’s effort as part of the Access to COVID-19 Tools (ACT) Accelerator, an international partnership of key global health actors to accelerate the development, production and equitable access to new technologies as part of the global response to the COVID-19 pandemic.
Key participating partners include the World Health Organization (WHO), which leads on the product allocation across all three partnerships of the ACT Accelerator in addition to coordinating the consolidated procurement platform for COVID-19 diagnostics; the World Bank; UNICEF; and Unitaid and others.
The Global Diagnostic Alliance (GDA) is a country-led alliance hosted by FIND that aims to sustainably change the diagnostics ecosystem. As part of its objective to enable an innovative platform, the GDA marketplace aims to provide visibility on the testing landscape and match demand and supply of quality essential diagnostics. The marketplace will be open to both the public and private sectors, and will serve the needs of domestic procurement
The objectives of the GDA marketplace are to:
- Increase availability of quality diagnostics through the online portal.
- Achieve sustainable prices through various market-shaping activities such as the pooling of demand.
- Disrupt downstream supply chain activities.
- Accelerate uptake of innovative and more cost-effective diagnostics.
- Support countries to transition to self-financing diagnostic demand
Buyers are able to access information and/or buy products available on the marketplace including diagnostics for Tuberculosis, Diabetes, Hepatitis C and HIV, Neglected Tropical Diseases and Malaria. Approved suppliers will be able to get connected to buyers via the marketplace and access reliable demand information for their products.